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Using in vitro engineered and transcribed reovirus m1 and s2 ssRNAs, we demonstrate that the nucleotides used to identify these ssRNAs are
localized to the 5′ and not the 3′ termini. To demonstrate this, we used our previously reported S2-CAT reovirus and we report the creation of an
engineered M1-CAT reovirus. The M1 gene of this virus retains 124 nucleotides from the wild type M1 gene preceding the CAT gene and 172
nucleotides from the wild type gene following the CAT gene. The engineered M1-CAT ssRNA is 1048 nucleotides in length, much shorter than the
wild type M1 at 2304 nucleotides. We have used a set of chimeric s2.m1 ssRNAs to localize the packaging signals within these RNAs. By packaging
signals we mean that the presence of these signals in engineered ssRNAs results in these ssRNAs being replicated to dsRNA and packaged into
progeny virus. An engineered ssRNAwith a 5′ sequence identical with the wild type s2 ssRNA, supported by a 3′ sequence from either the m1 or s2
ssRNA, is incorporated into a virus as an S2 dsRNA. Likewise, an ssRNAwith an m1 5′ end is incorporated as an M1 dsRNA.
© 2006 Elsevier Inc. All rights reserved.Keywords: Reovirus; Reverse genetics; M1 geneIntroduction
The Reoviridae family has proven to be resistant to reverse
genetics. The family contains more than 75 member species all
with genomes containing 10, 11 or 12 dsRNA segments (Patton
and Spencer, 2000; Ramig and Ward, 1991; Spence et al., 1984;
Urbano and Urbano, 1994). This is a diverse family with 4
genera infecting humans and the remaining 9, including a
proposed genus of insect reoviruses and several unassigned
members, infecting plants, insects, and fish. A reverse genetics
system has only been developed for two members, reovirus
(Roner et al., 2004; Roner and Joklik, 2001; Roner and Roehr,
2006) and recently rotavirus (Komoto et al., 2006). Work with
reovirus, 10 genome segments (Antczak and Joklik, 1992), and
rotavirus, 11 genome segments (Silvestri et al., 2004) suggests
that dsRNA formation is coordinated with packaging the viral
ssRNAs. These studies suggest that replication intermediates are
formed that contain the “packaged set” of ssRNAs, and when the⁎ Corresponding author. Department of Biology, The University of Texas at
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doi:10.1016/j.virol.2006.08.017process is completed, all the ssRNAs are immediately replicated
to dsRNA. This infers the ssRNAs contain the cis-acting
packaging signals as opposed to the dsRNA genome segments.
Our work with the reovirus s2 and m1 ssRNAs supports these
observations (Roner et al., 2004; Roner and Roehr, 2006). We
have previously localized the minimal sequences within the s2
ssRNA and now present our findings for the m1 ssRNA and two
chimeric s2.m1 ssRNAs. We demonstrate that the nucleotides
used to identify the chimeric ssRNAs are localized to the 5′ and
not the 3′ termini of the ssRNAs.
Results
Generation of an M1-CAT reovirus and identification of
minimal flanking sequences
Using the cDNA template pM1CAT1330 (Fig. 1), we have
transcribed an ssRNA and successfully incorporated it into a
stable reovirus (Fig. 1). The M1CAT viruses represent
approximately 10% of the viruses generated following lipofec-
tion of the M1CAT ssRNA together with a set of nine wild
type (wt) serotype three, strain Dearing (ST3D) ssRNAs. The
Fig. 1. M1CAT dsRNAs. The dsRNAs are listed using upper case letters, ssRNAs listed using lower case letters. (A) Autoradiogram of SDS-PAGE gel demonstrating
dsRNA genome segments of reovirus serotype 1, strain Lang (ST1), serotype 2, strain Jones (ST2J), serotype 3, strain Dearing (ST3D), M1 CAT 1330 and M1 CAT
1048 viruses. Cells were infected with each virus isolate and labeled with 32P. (B) Diagram depicting cDNA construction of plasmid pM1CAT1330.
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the wt M1 gene is the m1 ssRNA not removed following
cleavage treatment with the M1 antisense oligo and RNase H
treatment. The yield of S2CAT virus using this procedure has
always been approximately 15%. Reasons for this difference are
addressed in the discussion. The m1 ssRNA produced from the
cDNA template is 1330 bp in length. As shown in the
autoradiogram in Fig. 1, when this ssRNA is replicated to
dsRNA and incorporated into a virus, it has a migration rate
similar to the ST3D S1 dsRNAwhich is much larger at 1416 bp.
Sequencing the M1-CAT1330 dsRNA confirms that the RNA is
as engineered with a length of 1330 bp. The explanation for this
anomaly is that the secondary structure of dsRNAs in SDS-PAGE gels has a significant impact on their migration rates
(Clarke and McCrae, 1982; Roner and Joklik, 2001).
Using the methods we described for the s2 ssRNA (Roner et
al., 2004; Roner and Roehr, 2006), we have used the cDNA
pM1CAT1330 to find the minimal 5′ and 3′ flanking sequences
required for the m1 ssRNA to be incorporated into a reovirus.
We were able to reduce the total length of the m1-CAT ssRNA
from 1330 to 1048 nucleotides and produce a reovirus
containing this short m1 ssRNA. In Fig. 1, the genome
segments of this virus (ST3D with M1-CAT 1048) are shown.
This virus was produced by reducing the 5′ M1 nucleotides of
pM1CAT1330 from 343 to 124, and the 3′ nucleotide length
from 235 to 172 nucleotides. This ssRNA when replicated to
Fig. 2. M1CAT deletions. Detection of virus-generation intermediates using the
ssRNAs generated from the sequence-substitution cDNA templates outlined in
Table 1, using the reovirus infectious RNA system. The ssRNA (in the top
panel) and the CAT dsRNA (the second panel down) are shown utilizing
Northerns analyzing RNA extracted from cells lipofected 12 h earlier with 9
wild type ssRNAs and the ssRNA obtained following transcription of the
indicated cDNA template. The third and bottom panel is an autoradiogram
following SDS-PAGE generated by in vivo labeling with 32P of the dsRNA
genome segments of an isolated progeny virus containing the indicated mutated-
M1 dsRNA. Progeny virus generated following lipofection was first triple-
plaque purified.
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actual size than the 1330 dsRNA, when compared to the known
sizes of the remaining ST3D dsRNA segments. Again, se-
quencing of this dsRNA confirms its engineered sequence and
length. To discover the 5′minimum of 124 and the 3′ minimum
of 172, we initially made large deletions of these regions
followed by individual nucleotide deletions, as we reported for
the s2 ssRNA (Roner et al., 2004; Roner and Roehr, 2006).
These deletions are summarized in Table 1 and the in vivo
activity of the created ssRNAs is shown in Fig. 2.
Activity of chimeric ssRNAs using single gene knock-out
acceptor RNA sets
Two chimeric ssRNAs were created using the minimum 5′
and 3′ sequences identified for the s2 and m1 ssRNAs. The
ssRNAs contained 5′ and 3′ sequences from either the s2 or m1
ssRNAs, flanking the CAT gene. The chimeric ssRNAs 5′S2-
CAT-M13′ and 5′M1-CAT-S23′ are only slightly different in
length than the starting ssRNAs 5′S2-CAT-S23′, from plasmid
pS2CAT3 m (Roner and Roehr, 2006), and 5′M1-CAT-M13′,
from plasmid pM1CAT1048. Outlined in Fig. 3 is a summary of
the lipofection procedure, an SDS-PAGE gel showing the
dsRNA genome segments of the chimeric viruses and a table
summarizing the structure of the ssRNAs. Fig. 4 summarizes the
activity of these ssRNAs when lipofected into cells to produce
recombinant viruses.
Individually the two chimeric ssRNAs were tested for
activity using single knock-out sets of 9 ssRNAs created by
removing either the s2 or m1 ssRNA as described. The ssRNA
sets were then lipofected into the cell line providing the protein
coded for by the deleted gene and any virus produced during the
next 48 h screened for on the same cell line. Multiple samples
were harvested for screening, for analysis to confirm the
presence of the lipofected CAT ssRNA and to detect any CAT
dsRNA that was produced. In Fig. 4A, the first two ssRNAs are
the controls previously described, pS2CAT3 m listed as 5′S2-Table 1
The minimal flanking sequences of the m1-CAT ssRNA
cDNA clone Length of 5′ M1
sequence
Length of 3′ m1
sequence
CAT
activity
pM1CAT1330 343 235 64
pM1CAT1187 200 235 <4
pM1CAT1137 150 235 <4
pM1CAT1117 130 235 64
pM1CAT1112 125 235 <4
pM1CAT1111 124 235 64
pM1CAT1110 123 235 <4
pM1CAT1087 100 235 32
pM1CAT1077 124 200 84
pM1CAT1051 124 175 64
pM1CAT1050 124 174 64
pM1CAT1049 124 173 32
pM1CAT1048 124 172 64
pM1CAT1047 124 171 64
pM1CAT1046 124 170 32
pM1CAT1026 124 150 32
a See Fig. 2.CAT-S23′ to highlight the source of the 5′ and 3′ sequences, and
pM1CAT1048 listed as 5′M1-CAT-M13′ to again highlight the
source of the 5′ and 3′ sequences. The third, fourth and fifth
ssRNAs 5′S2-CAT-M13′ contain the minimum s2 5′ region and
the minimum m1 3′ region flanking the CAT sequence. This
ssRNA was tested using three core RNA sets, for the ability tossRNA
detected a
dsRNA
detecteda
Engineered RNA incorporated
into infectious virusa
+ + +
+ + +
+ + +
+ + +
+ + +
+ + +
+ − −
+ − −
+ + +
+ + +
+ + +
+ + +
+ + +
+ − −
+ − −
+ − −
Fig. 3. Incorporation of chimeric ssRNA into reovirus. (A) Summary of lipofection virus generation experiments used to test chimera ssRNAs for incorporation into progeny virus. (B) Autoradiogram of SDS-PAGE gel
demonstrating dsRNA genome segments of reovirus serotype 3, strain Dearing (ST3), S2-CAT (5′S2-CAT-S23′), M1-CAT (5′M1-CAT-M13′), chimera M1/S2 viruses (5′M1-CAT-S23′, 5′S2-CAT-M13′) and viruses
containing two engineered genes (5′S2-CAT-S23 and 5′M1-CAT-M13) and (5′M1-CAT-S23′ and 5′S2-CAT-M13′). (C) Table summarizing structure of CAT ssRNAs.
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Fig. 4. Chimeric ssRNAs. (A) A table summarizing the activity of the chimeric ssRNAs we constructed and tested for their ability to generate recombinant viruses. The
engineered RNAs are shown, the acceptor sets of 8 or 9 RNAs with which the engineered RNAs were mixed with to generate virus, together with the initial cell line in
which virus generation occurred and the cell line used to screen for progeny virus that was generated. The genotype of the inserted dsRNA in progeny virus produced
as well as detection of the lipofected CAT ssRNA and any CAT dsRNA produced is indicated. (B) Two Northerns. The ssRNA (in the top panel) and the CAT dsRNA
(the second panel down) are shown utilizing Northerns analyzing RNA extracted from cells lipofected 12 h earlier with 9 or 8 wild type ssRNAs and the ssRNA
obtained following transcription of the indicated cDNA template.
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the chimeric ssRNA 5′S2-CAT-M13 was incorporated into an
infectious reovirus in place of the S2 dsRNA, but never in place
of the M1 dsRNA, Fig. 4A, RNAs 3 and 4. The sixth, seventh
and eighth ssRNAs5′M1-CAT-S23′ contain the minimum m1 5′
region and the minimum s2 3′ region flanking the CAT
sequence. This ssRNAwas tested using three core RNA sets, for
the ability to be incorporated as an m1 or s2 ssRNA, or both. We
found the chimeric ssRNA5′M1-CAT-S23′ was incorporated
into an infectious reovirus in place of the M1 dsRNA, but never
in place of the S2 dsRNA, Fig. 4A, RNAs 6 and 7. The activity
of these ssRNAs when added to sets of 8 ssRNAs is presented
next, Fig. 4A, RNAs 5 and 8.
Activity of chimeric ssRNAs using double gene knock-out
acceptor RNA sets
Using a dual-knock-out set of eight ssRNAs, we examined
the capacity of individual ssRNAs to replace both the wt s2 and
m1 ssRNAs. The capacity of the chimeric ssRNAs 5′S2-CAT-
M13 or 5′M1-CAT-S23′ to individually replace both the s2 andm1 ssRNAs was tested, Fig. 4A, RNAs 5 and 8. In these
experiments, neither chimeric ssRNAwas ever incorporated into
an infectious reovirus in place of both the S2 and M1 dsRNAs.
Even though the chimeric ssRNAs were never replicated to
dsRNA or incorporated into virus, they were stable and readily
detected within the lipofected cells, suggesting that degradation
was not the reason for inactivity, Fig. 4B.
We then examined the capacity of the chimeric ssRNAs 5′S2-
CAT-M13 and5′M1-CAT-S23′ together to replace both the s2
and m1 ssRNAs in an individual virus, Fig. 4A, RNAs 9 and 10.
Together the ssRNAs and double knock-out acceptor RNAs
were lipofected into the cell line providing both the σ2 and μ2
proteins and any virus produced during the next 48 h screened
for on the same cell line. Multiple samples were harvested for
screening, for analysis to confirm the presence of the lipofected
CAT ssRNA, and to detect any CAT dsRNA that was produced.
We found that the 5′S2-CAT-S23′ ssRNA could replace the wt
s2 and the 5′M1-CAT-M13′ ssRNA could replace the wt m1 and
both be replicated to dsRNAyielding a stable virus with both an
S2-CAT and M1-CAT gene, Fig. 4A, RNA 9, and Fig. 3B.
When both chimeric ssRNAs were combined with a set of eight
94 M.R. Roner, B.G. Steele / Virology 358 (2007) 89–97ssRNAs missing both the s2 and m1 ssRNAs, these chimeric
ssRNAs were detectable, replicated to dsRNA and incorporated
into virus in place of the deleted s2 and m1 ssRNAs, Fig. 4A,
RNA 10, and Fig. 3B. The S2 dsRNA was always 5′S2-CAT-
M13 and the M1 dsRNA always5′M1-CAT-S23′.
Discussion
This work summarizes our expansion of the reovirus genetics
system to include theM1 gene and chimeric s2.m1 ssRNAs. The
M1-CAT virus is 10% of total virus generated while S2-CAT is
15% of total. The primary reason for this difference in efficiency
is that we found removal of the wt ST3D m1 ssRNA using an
oligo and RNase H to be less efficient than removal of s2 ssRNA
using the same method. This is likely due to intrinsic properties
of the oligo selected, and possibly the m1 ssRNA secondary
structure at or near the oligo binding site. As for the oligo used to
remove the s2 ssRNA, the oligo selected for the m1was based on
efficient cleavage of the wt m1 ssRNA and minimal cleavage of
the remaining 9 ssRNAs. The efficiency in generating an M1-
CAT reovirus was still high enough to allow isolation of all the
engineered viruses.
The engineered M1-CAT ssRNA is 1048 nucleotides in
length, much shorter than the wild type m1 at 2304 nucleotides.
The M1 gene of the virus generated from this ssRNA retains
124 nucleotides from the wild type M1 gene preceding the CAT
gene and 172 nucleotides from the wild type gene following the
CAT gene. The minimal m1 sequences flanking the CAT gene
required by the ssRNA to be recognized as a reovirus m1
ssRNA, replicated to a dsRNA and incorporated into a progeny
virus as an M1 genome segment, are greater than those required
by the s2-CAT ssRNA. For the m1-CAT ssRNA 5′, 124
nucleotides versus 96 for the s2, and for the m1 3′ 172
nucleotides versus 98 for the s2. We are working on the l1
ssRNA and will know soon if the correlation between genome
length and increasing length for the required 5′ and 3′ sequences
seen from the s2 to the m1 extends to the larger reovirus genes.
We have used a set of chimeric s2.m1 ssRNAs to localize the
packaging signals within these RNAs. Using in vitro engineered
and transcribed reovirus m1 and s2 ssRNAs, we demonstrated
that the nucleotides used to identify these ssRNAs are localized
to the 5′ and not the 3′ termini. An engineered ssRNAwith a 5′
sequence identical with the wild type s2 ssRNA, supported by a
3′ sequence from either the m1 or s2 ssRNA, is incorporated
into a virus as an S2 dsRNA. Likewise, an ssRNAwith an m1 5′
end is incorporated as an M1 dsRNA.
We have spent a notable amount of time examining RNA
secondary structures predicted to be present in the required 5′ and
3′ regions of the s2 and m1 ssRNAs for conserved structures. To
date we have found only the previously discussed structure,
involving a loop containing a free A-U-U, predicted to be present
in the 5′ ends of all ten reovirus ssRNAs (Roner et al., 2004). We
know that the s2 ssRNA contains anAUU sequence involved in a
predicted secondary structure that if mutated prevents the RNA
from being incorporated into a recombinant virus (Roner et al.,
2004). The m1 ssRNA also contains a similar sequence although
we have been unable to demonstrate a functional role for theAUU sequence in the m1 ssRNA. Deletion of the sequence does
not destroy activity of the m1-CATssRNA (data not shown). We
are creating new chimeric ssRNAs containing portions of the 5′
regions of both the s2 and m1-CAT ssRNAs to isolate the
sequences in the 5′ region that identify the s2 as a reovirus s2
ssRNA and the m1 as an m1 ssRNA.
Work with phi 6 (Mindich, 2004; Pirttimaa and Bamford,
2000; Poranen and Tuma, 2004) has determined that during
normal assembly each virus particle contains only one copy of
each ssRNA. This “assortment” is possible due to the presence of
packaging signals (pac sites) which have been mapped to the 5′
ends of the RNA segments. In addition to the sequences of these
pac sites, RNA secondary structure is also important for activity.
Based on our findings with the s2 and m1 ssRNAs, we believe a
unique sequence/structure also exists in the 5′ regions of the
reovirus ssRNAs. Using our data, the 3′ regions of the reovirus
ssRNAs are required for the RNAs to be replicated to dsRNA,
but this can only occur after the sequences in the 5′ region have
been used to identify the ssRNAs as either a reovirus s2 or m1
ssRNA. If we engineer an ssRNA to contain an s2 5′ region, the
ssRNA is treated as an s2 ssRNA. Replacing the 5′ region with
an m1 sequence results in the ssRNA being replicated and
assorted as an m1 ssRNA. The 3′ regions of these ssRNAs are
not just “filler” as replacement of these regions with a sequence
other than the identified s2 or m1 sequences produces an ssRNA
that is “dead” in the reovirus system, never replicated to dsRNA
and never incorporated into a virus (data not shown).
We demonstrate in this report that the reovirus system can be
used to create a two-CAT gene engineered virus from two in
vitro transcribed ssRNAs. The 5′ nucleotide sequence flanking
the CAT gene is used to identify the ssRNAs as “s2” or “m1”
and leads to the replication of the ssRNAs to dsRNA and
incorporation into an infectious reovirus.
Neither the 5′S2-CAT-M13 nor the 5′M1-CAT-S23 ssRNA is
able to take the place of both the s2 andm1 ssRNAs and generate
a virus with two copies of either of these genes, even when the
proteins encoded by both genes are present. This result supports
our hypothesis that the reovirus assortment process requires not
only 10 ssRNAs, but the signals from 10 ssRNAs. If this were
incorrect, we would have expected a virus to be generated that
had eight genes with the 5′S2-CAT-M13 or the 5′M1-CAT-S23 as
the ninth gene. Alternatively, we could have generated a virus
with eight genes and two copies of either the 5′S2-CAT-M13 or
the 5′M1-CAT-S235′M1-CAT-S23 as the ninth and tenth genes.
When both the 5′S2-CAT-M13 and the 5′M1-CAT-S23 are
added to a set of eight ssRNA depleted of the wt s2 and m1
ssRNAs, at least four outcomes were possible. Neither ssRNA
could have been incorporated and no virus generated; this did
not occur. Two copies of either CAT ssRNA could have been
incorporated to generate a virus with 10 genome segments, but
two copies of one; this did not occur. One copy of either CAT
ssRNA could have been incorporated into a nine-genome
segment stable reovirus; this did not occur. Additionally, one
copy of each CAT ssRNA could have been incorporated into a
10-genome segmented virus; this is what we isolated. One copy
of each ssRNA, the 5′S2-CAT-M13 and 5′M1-CAT-S23 was
incorporated into a virus with eight wt genes. Based on our
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determines the identity of the ssRNA and subsequent dsRNA,
the ssRNA 'S2-CAT-M13 was incorporated in place of the wt
S2 dsRNA and the ssRNA 5′M1-CAT-S23 as the wt M1 dsRNA.
In summary, the reovirus system will allow researchers to
engineer any reovirus gene within the limits of required 5′ and
3′ sequence elements. Extension of our work to the L1 and
additional genes will add additional data from which a model
for reovirus genome packaging and replication will be built.
Materials and methods
Virus and cell lines
Reovirus ST3, strain Dearing (ST3D) and reovirus ST2,
strain Jones (ST2J) were used. The recombinant viruses
containing the CAT gene were grown in L929 cells transformed
with pHβAPr-1-neo (Gunning et al., 1987) that contain the
ST3D S2 (L-ST3.S2) (Roner and Roehr, 2006) or the ST3D M1
cDNA (L-ST3.M1) under the control of the human β actin
promoter. The L-ST3.M1 cells express protein μ2 that is
sufficient to rescue ts H (Ito and Joklik, 1972), a ST3D virus
mutant with a ts mutation in the M1 genome segment. To create
a cell line expressing two reovirus proteins, we started with the
L-ST3.S2 cell line. This cell line was transfected with the
Promega vector pTARGET (#A1410) containing the reovirus
ST3D M1 coding sequence cloned into the SmaI site. Cells
were selected in the presence of G418 and clones expressing
both σ2 and μ2 identified by western blots, SDS-PAGE and the
ability of the cell clones to support the replication of both
reovirus temperature sensitive mutants ts C and ts H at the
nonpermissive temperature of 39.5 °C. The cell line was
designated L-ST3.S2.M1.
The reovirus reverse genetics system
The system was used as described (Roner et al., 2004; Roner
and Joklik, 2001; Roner and Roehr, 2006; Roner et al., 1990).
ST3D capped and methylated mRNA (referred to as ssRNA)
was transcribed by cores (Skehel and Joklik, 1969). After
transcription, the cores were pelleted at 10,000×g; the super-
natant, which contained the ssRNA was then made 0.5% with
respect to sodium dodecyl sulfate (SDS) and extracted three
times with phenol/chloroform. The RNA was precipitated with
polyethylene glycol (PEG), reextracted three times with phenol/
chloroform and precipitated with 2.5 M ammonium acetate and
ethanol. Single-stranded RNA prepared in this manner
contained no residual infectious virus. For all lipofections, we
used 10 μl of Rabbit Reticulocyte Lysate (Promega #L4960)
primed with 0.3–0.5 μg of ST3D ssRNA (this ssRNA is the
acceptor set missing either the s2, m1 or both the s2 and m1
ssRNAs and prepared as described in “Removal of wt s2 and m1
ssRNAs to create the accepter ssRNA sets”) and 0.1 μg of the
indicated s2, m1 or chimeric ssRNA (obtained from in vitro
transcription using T7 RNA polymerase and the indicated
cDNA template, Promega-RiboMAX™-T7) and 12 units of
RNasin Plus RNase Inhibitor (Promega) in a total of 1 μl H2O.Translation was allowed to proceed for 1 h at 30 °C. After
translation, an additional 0.3–0.5 μg of ST3D ssRNA in 1 μl
H2O was added and the mixture was immediately added to
0.5 ml of MEM containing penicillin and streptomycin and
50 μl of Lipofectin, or Lipofectamine (Invitrogen Corporation).
This mixture was immediately added to PBS-washed mono-
layers of 106 mouse L929 fibroblasts (L-ST3.S2, L-ST3.M1 or
L-ST3.S2.M1) in 6-well multiplates. After 6 h, this mixture was
replaced with 0.25 ml of MEM containing 4×107 PFU of ST2J
reovirus, and 1 h later 1.75 ml of MEM containing 5% fetal
bovine serum was added. After 24 h, the cells were harvested,
washed twice in MEM and sonicated in 2 ml of MEM, and virus
in the sonicates was titrated on monolayers of the same cell line.
To avoid detection of the ST2J helper virus, plaques were
counted and selected on day 5, when plaques formed by ST2J
virus were not yet detectable.
Removal of wt s2 and m1 ssRNAs to create the accepter ssRNA
sets
Wild type s2 ssRNA was removed from the mixture of 10
ssRNA species as previously described (Roner et al., 1997).
Briefly, the DNA oligonucleotide selected for this purpose was
complementary to nucleotides 937–949; and 10 pmol was added
to 2 pmol of s2 ssRNA. After hybridization, the mixture was
treated with RNAse H for 20 min. The RNAwas extracted three
times with phenol/chloroform and precipitated with sodium
acetate. Degradation of the s2 ssRNA was confirmed by gel
electrophoresis of both the RNA and its translation products.
Similarly, the m1 ssRNA was removed from the mixture of
10 ssRNA species using the DNA oligonucleotide complemen-
tary to nucleotides 521–532; 10 pmol were added to 2 pmol of
m1 ssRNA. Degradation of the m1 ssRNA was confirmed by
gel electrophoresis of both the RNA and its translation products.
The set of nine ssRNAs could then be supplemented with the
engineered in vitro transcribed m1-CAT ssRNA. To create the
acceptor sets missing both the s2 and m1 ssRNAs, the s2 was
removed first followed by the m1.
Engineering of reovirus S2 and M1 cDNAs used to generate
the engineered ssRNAs
As previously described, we can incorporate an engineered
reovirus s2 ssRNA into the reovirus genome as a stable dsRNA
genome segment (Roner et al., 2004; Roner and Joklik, 2001;
Roner andRoehr, 2006).We used the same procedure to generate
the M1-CAT cDNA template. For the M1 cDNA template, 343
nucleotides from the wild type M1 gene precede the CAT gene
and 235 nucleotides from the wild type gene follow the CAT
gene and generate the 3′ end of the ssRNA. This template is
transcribed by T7 RNA polymerase to yield an RNA transcript
that possesses 5′ and 3′ terminal sequences as authentic m1
ssRNA. Transcription by T7RNA polymerase is terminatedwith
the T7 terminator sequence located 3′ of this construct.
Transcription of this construction yielded an RNA that contained
the 343 5′ nucleotides of m1 RNA fused in frame to the CAT
mRNA sequence followed by the 235 3′ terminal nucleotides of
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sequence in such a way that when the ribozyme underwent auto-
cleavage, it left a terminal C at the 3′ terminus. As a result, the 3′
terminal sequence of the transcript was the authentic reovirus
RNA 3′ terminal sequence—UCAUC. Recloning and subse-
quent sequencing and cleavage analysis confirmed the authen-
ticity of the 5′ and 3′ terminal sequences. This cDNA template,
pM1CAT1330, is summarized in a diagram in Fig. 1.
The pM1CAT1330 construct was transcribed in vitro using
T7 RNA polymerase and the transcript was capped using m7
GpppG (Promega) to yield s2-CAT mRNA. It was translated in
vitro using a rabbit reticulocyte lysate system (Promega) and the
lysate was found to contain CAT activity (CAT-ELISA,
Boehringer Mannheim Corporation). This ssRNA was used to
supplement the acceptor ssRNA sets and lipofected into cells to
generate virus.
Mutagenesis of 5′ and 3′ m1 sequences flanking the CAT gene
in construct pM1CAT1330
Sequential deletion and mutagenesis of the 5′ and 3′ M1-
CAT flanking sequences was carried out using GeneEditor by
Promega (#Q9280). This system uses antibiotic selection to
obtain a high frequency of mutants. Selection oligonucleotides
provided with the GeneEditor System encode mutations that
alter the ampicillin resistance gene, creating a new additional
resistance to the GeneEditor Antibiotic Selection Mix. As
directed by the manufacturer, we annealed the selection
oligonucleotide to our pM1CAT1330 double-stranded DNA
template at the same time as a mutagenic oligonucleotide.
Subsequent synthesis and ligation of the mutant strand link the
two oligonucleotides. The mutagenic oligonucleotides we
selected were all 50 or more nucleotides in length, 25
nucleotides matching the M1 and/or CAT nucleotide sequence
depending upon the location of the sequence we wished to
retain and 25 nucleotides matching the HDV-ribozyme nucleo-
tide sequence. Using 25 perfectly matched nucleotides on each
side of the mismatched sequence we wished to loop-out and
remove, we were able to remove nucleotides from the original
pM1CAT1330 sequence. We initially made large 50 base
deletions and narrowed down sequence using single nucleotide
deletions. The results are summarized in Table 1 and Fig. 2.
Construction of chimeric cDNA templates
As outlined in Fig. 3, part C, the 5′S2-CAT-S23′ cDNA is
identical to the pS2CAT3 m template (Roner and Roehr, 2006)
and the 5′M1-CAT-M13′ cDNA is identical to the pM1CAT1048
template described in this paper. Mutagenesis of these templates
to yield the chimeric cDNAs 5′S2-CAT-M13′ and 5′M1-CAT-
S23′ was carried by swapping restriction fragments. Briefly, the
5′ fragment from the multiple cloning site (MCS, HindIII) to an
internal EcoR1 within the CAT gene (#247) was excised from
both pS2CAT3 m and pM1CAT1048 and exchanged with each
other to yield5′M1-CAT-S23′ and 5′S2-CAT-M13′. A partial
EcoR1 digest was required as an additional EcoR1 site exists at
the 3′ end of the cDNAs, a remnant of the original MCS. Thefinal length of the ssRNAs transcribed from these cDNAs is
summarized in Fig. 3, part C.
Virus titration/determination of CAT activity
Monolayers of lipofected and infected L-ST3.S2, L-ST3.M1
or L-ST3.S2.M1 cells were incubated at 37 °C for 5 days.
Neutral red was added 24 h before counting plaques (Roner et
al., 2004; Roner and Joklik, 2001; Roner and Roehr, 2006). CAT
activity in cell lysates was assayed using CAT ELISA
(Boehringer Mannheim Corporation). We measure the CAT
activity of our engineered viruses as a method to screen large
numbers of recombinant viruses when we encounter ssRNAs
that are inefficiently incorporated in progeny viruses. Although
useful this activity is not used to confirm that we have generated
a recombinant virus. The CATactivity is low as it is expressed as
a σ2-CAT or μ2 fusion protein. The engineered dsRNAs of all
recombinant viruses were sequenced to confirm the presence of
the indicated genome segment and its exact nucleotide sequence.
Detection of reovirus s2 and m1 ssRNAs in vivo
Twelve hours following lipofection of L929 or L-ST3.S2, L-
ST3.M1 or L-ST3.S2.M1 cells with the indicated ssRNAs,
protein translation mixture and infection with reovirus serotype
2 helper virus, total RNA was extracted from the cell
monolayers using Eppendorfs' Perfect RNA Eukaryotic Mini
kit and protocols. The ssRNA was electrophoresed in a
formaldehyde denaturing gel using Ambion, Inc.'s North-
ernMax kit. Following the manufacturer's protocol, the ssRNA
was transferred to a BrightStar-Plus Positively Charged Nylon
Membrane and UV-cross linked. Hybridization/detection was
carried out at 40 °C according to manufacturer's directions
using UltrahybTM buffer and 32P-labeled oligonucleotides. For
detecting the ST3D s2 ssRNA, the oligonucleotide (S2.5) 5′
CAAACCACCAGACGTTTTACACGGTTAATTGCTGCTT-
GATA3′ complementary to nucleotides 55 to 95 near the 5′
end of the s2 RNA was used. The oligonucleotide S2.5 was
selected because it is 19.5% mismatched with the ST2J s2
sequence and, when used as an ssRNA probe, does not detect
the ST2J s2 ssRNA or the S2 dsRNA genome segment. For
detecting the ST3D m1 ssRNA, the oligonucleotide (M1.5) 5′
GAACGACATTCGCGTCAGCCCCAGCGTCTACTC-
CAAACG3′ complementary to nucleotides 120 to 81 near the
5′ end of the m1 RNA was used. The oligonucleotide M1.5
was selected because it is 42% mismatched with the ST2J m1
sequence and, when used as an ssRNA probe, does not detect
the ST2J m1 ssRNA or the M1 dsRNA genome segment. For
detecting the s2/CAT or m1/CAT ssRNA, the oligonucleotide
(CAT.1) 5′TTTACGATGCCATTGGGATATATCGGTGGTA-
TATCC3′ complementary to CAT gene was used. The mem-
brane was used to expose X-ray film.
Detection of reovirus CAT/S2 and CAT/M1 dsRNA in vivo
Twelve hours following lipofection of L929 or L-ST3.S2, L-
ST3.M1 or L-ST3.S2.M1 cells with the indicated ssRNAs,
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2 helper virus, total cell monolayers were harvested. The
dsRNAwas electrophoresed in 7.5% SDS-PAGE gels for 2650
volt/h as described (Moody and Joklik, 1989). Following the
protocol used for the ssRNA gels, the dsRNAwas transferred to
a BrightStar-Plus Positively Charged Nylon Membrane and
UV-cross linked. Hybridization/detection was carried out at
40 °C according to manufacturer's directions, using Ultra-
hybTM buffer and 32P-labeled oligonucleotides. For detecting
the s2/CAT or m1/CAT ssRNA, the oligonucleotide CAT.1
(Roner et al., 2004) complementary to CAT gene was used. The
membrane was used to expose X-ray film.
Recombinant virus purification
Forty-eight hours following lipofection of L929 or L-ST3.
S2, L-ST3.M1 or L-ST3.S2.M1 cells with the indicated
ssRNAs, protein translation mixture and infection with reovirus
serotype 2 helper virus, total cell monolayers were harvested.
Serial 10-fold dilutions were prepared from these lysates and
monolayers of L929 or L-ST3.S2, L-ST3.M1 or L-ST3.S2.M1
cells were infected. After incubation at 37 °C for 5 days, neutral
red was added 24 h before counting plaques (Roner et al., 2004;
Roner and Joklik, 2001). Visualized plaques were selected
using Pasteur pipettes and placed in 1 ml MEM without serum.
This plaque-purification process was repeated three times. The
dsRNA genomes of each three-time plaque-purified isolate
were then analyzed by SDS-PAGE. In summary, individual
wells of 96 well plates of L929 or L-ST3.S2, L-ST3.M1 or L-
ST3.S2.M1 cells were infected with 50 μl of each isolate. After
incubation at 37 °C for 24 h, 1 μCi 32P orthophosphate was
added to each well. After an additional 24 h, 50 μl 2× Laemmli
sample buffer was added to each well and the plates stored at
−20 °C. The plates were heated to 65 °C for 10 min and 10 μl of
each well loaded onto a 7.5% SDS-PAGE gel and electrophor-
esis carried out for 2650 volt/h. The gels were immediately
dried and used to expose X-ray film. For recombinant viruses
that should have the CAT gene expressed in frame, CAT activity
was checked as an additional screen, and all recombinant
reoviruses were identified by sequencing of the engineered
dsRNAs to confirm that the engineered ssRNA made in vitro
had been incorporated as constructed.
Sequencing of cDNA templates and recombinant viruses
All cDNA templates were sequenced to confirm the presence
of the desired mutations. The T7-generated ssRNAs were
sequenced using two methods: the 5′ 200 nucleotides
sequenced using reverse transcriptase (RT) and a complemen-
tary primer, the 3′ ends first poly-A tailed using yeast poly-A
polymerase, then sequenced using RT and an oligo-T primer, as
described (Roner et al., 2004; Roner and Joklik, 2001; Wiener et
al., 1989). Following purification, all recombinant reoviruses
were propagated and the engineered dsRNA genome segments
sequenced directly using reverse transcriptase as described
(Wiener et al., 1989).Acknowledgments
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